According to a new report Asia Pacific Artificial Intelligence in Diagnostics Market, published by KBV research, the Asia Pacific Artificial Intelligence in Diagnostics Market would witness market growth of 29.2% CAGR during the forecast period (2020-2026).
The China market dominated the Asia Pacific Chest & Lungs Market by Country in 2019. The India market is experiencing to witness a CAGR of 36.6% during (2020 - 2026). Additionally, The Japan market is anticipated to witness a CAGR of 36.6% during (2020 - 2026).
The Software market dominated the South Korea Artificial Intelligence in Diagnostics Market in 2019, thereby, achieving a market value of $15.3 Million by 2026. The Services market is exhibiting a CAGR of 36.5% during (2020 - 2026). Additionally, The Hardware market is expected to witness a CAGR of 33.8% during (2020 - 2026).
The Neurology market dominated the Malaysia Artificial Intelligence in Diagnostics Market by Diagnosis Type in 2019, growing at a CAGR of 35.6 % during the forecast period. The Oncology market is estimated to grow at a CAGR of 36% during (2020 - 2026).
Structural Insights: https://www.kbvresearch.com/asia-pacific-artificial-intelligence-diagnostics-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of General Electric (GE) Co. (GE Healthcare), Siemens AG (Siemens Healthineers), Aidoc Medical Ltd., AliveCor, Inc., Imagen Technologies, Inc., VUNO, Inc., IDx Technologies, Inc., NovaSignal Corporation, Riverain Technologies, LLC, and Zebra Medical Vision Ltd.
By Diagnosis Type
By Component
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
